Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple Myeloma
Clinical trial NCT05363111 · RECRUITING
Trial details
- NCT number
- NCT05363111
- Sponsor
- City of Hope Medical Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-22
- Primary completion
- 2027-03-23
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.